SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Restructurings
An SI Board Since September 2002
Posts SubjectMarks Bans
270 25 0
Emcee:  rkrw Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
170COLY -22% Coley Ends Actilon Program, Cuts Staff Monday January 22, 5:01 pm ET Icebrg-1/23/2007
169This excerpt from today’s GENR PR is a gem: biz.yahoo.com >> <i>“ADewDiligence_on_SI-1/3/2007
168Trodusquemine for obesity is not a bona fide drug candidate and it will never amDewDiligence_on_SI-1/3/2007
167GENR - 30% LOS ANGELES, Jan 3 (Reuters) - Genaera Corp. (GENR.O: Quote, ProfileIcebrg-1/3/2007
166NeoPharm cuts 20% of jobs Cancer drug's failure ripples through company DecIcebrg-12/27/2006
165Trimeris Announces Strategic Shift Tuesday November 14, 4:00 pm ET -- Company scaram(o)uche-11/14/2006
164Has there been a worse biotech acquisition than OSI's acquisition of EyetechFiloF-11/8/2006
163Corautus Genetics To Replace CEO, CFO localtechwire.com ATLANTA – Corautus Genettnsaf-11/8/2006
162OSI to leave eye-drug business The company may sell or license Macugen, which hatnsaf-11/8/2006
161Crucell (CRXL) 21% Message 22956756 60 gone out of 282 (as of last December). tuck-10/30/2006
160MOGN 10% Message 22945338 Cheers, Tucktuck-10/26/2006
159MLNM - 14 % Overall, headcount will decrease by approximately 14 percent, resulIcebrg-10/26/2006
158DOV Pharmaceutical, Inc. Announces New Strategic Direction, Bicifadine Clinical nigel bates-10/10/2006
157Neose (NTEC) 25%: >>HORSHAM, Pa.--(BUSINESS WIRE)--Sept. 5, 2006--Neose Ttuck-9/5/2006
156Gene Logic--80 from genomics divisionMike McFarland-8/2/2006
155NBIX - one salesforce. Message 22660197Icebrg-7/26/2006
154NPSP 53%: Message 22534788 Cheers, Tucktuck-6/12/2006
153Volume increase on Tripos today <img src='http://ichart.finance.yahoo.comMike McFarland-5/18/2006
152NEOL - 23% NeoPharm Announces Cost Rationalization Program Friday April 28, 5:0Icebrg-4/29/2006
151Can you read the following sentence out loud in one breath? "As a result oMike McFarland-3/6/2006
150That sheds some light on Santi's emmigration. Didn't want to be viewed keokalani'nui-3/2/2006
149KOSN 33% AYWARD, Calif., March 2 /PRNewswire-FirstCall/ -- Kosan Biosciences InIcebrg-3/2/2006
148TGEN 27% >>SEATTLE--(BUSINESS WIRE)--Jan. 24, 2006--Targeted Genetics Cortuck-1/24/2006
147Tripos, final numbers, 76 employees, 'shuttering a 6,000-square-foot temporMike McFarland-1/24/2006
146Seems DNDN will play with the cards they are holding. Story is expanded in SeattSteve Lokness-1/21/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News